🚀 VC round data is live in beta, check it out!
Outset Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Outset Medical and similar public comparables like electroCore, Pangaea Oncology, Optomed, Accuray and more.
Outset Medical Overview
About Outset Medical
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Founded
2003
HQ
Employees
310
Website
Financials (LTM)
Market Cap
$64M
Outset Medical Financials
Outset Medical reported last 12-month revenue of $121M and negative EBITDA of ($45M).
In the same LTM period, Outset Medical generated $49M in gross profit, ($45M) in EBITDA losses, and had net loss of ($77M).
Revenue (LTM)
Outset Medical P&L
In the most recent fiscal year, Outset Medical reported revenue of $120M and EBITDA of ($46M).
Outset Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $121M | XXX | $120M | XXX | XXX | XXX |
| Gross Profit | $49M | XXX | $47M | XXX | XXX | XXX |
| Gross Margin | 41% | XXX | 39% | XXX | XXX | XXX |
| EBITDA | ($45M) | XXX | ($46M) | XXX | XXX | XXX |
| EBITDA Margin | (37%) | XXX | (39%) | XXX | XXX | XXX |
| EBIT Margin | (41%) | XXX | (42%) | XXX | XXX | XXX |
| Net Profit | ($77M) | XXX | ($82M) | XXX | XXX | XXX |
| Net Margin | (63%) | XXX | (68%) | XXX | XXX | XXX |
| Net Debt | — | — | $61M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Outset Medical Stock Performance
Outset Medical has current market cap of $64M.
Market Cap Evolution
Outset Medical's stock price is $3.50.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $64M | 0.0% | XXX | XXX | XXX | $-4.46 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOutset Medical Valuation Multiples
Outset Medical trades at (0.0x) EV/Revenue multiple, and 0.1x EV/EBITDA.
EV / Revenue (LTM)
Outset Medical Financial Valuation Multiples
As of March 31, 2026, Outset Medical has market cap of $64M.
Equity research analysts estimate Outset Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Outset Medical has a P/E ratio of (0.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $64M | XXX | $64M | XXX | XXX | XXX |
| EV (current) | ($4M) | XXX | ($4M) | XXX | XXX | XXX |
| EV/Revenue | (0.0x) | XXX | (0.0x) | XXX | XXX | XXX |
| EV/EBITDA | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBIT | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/Gross Profit | (0.1x) | XXX | (0.1x) | XXX | XXX | XXX |
| P/E | (0.8x) | XXX | (0.8x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 0.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Outset Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Outset Medical Margins & Growth Rates
Outset Medical's revenue in the last 12 month grew by 7%.
Outset Medical's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.4M for the same period.
Outset Medical's rule of 40 is (28%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Outset Medical's rule of X is (19%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Outset Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | (37%) | XXX | (39%) | XXX | XXX | XXX |
| EBITDA Growth | (8%) | XXX | (7%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (28%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (19%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 43% | XXX | 45% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 24% | XXX | 32% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 15% | XXX | 18% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 95% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Outset Medical Public Comps
See public comps and valuation multiples for other Medical Devices and Mental Health Technology comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| electroCore | XXX | XXX | XXX | XXX | XXX | XXX |
| Pangaea Oncology | XXX | XXX | XXX | XXX | XXX | XXX |
| Optomed | XXX | XXX | XXX | XXX | XXX | XXX |
| Accuray | XXX | XXX | XXX | XXX | XXX | XXX |
| Optiscan Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Outset Medical M&A Activity
Outset Medical acquired XXX companies to date.
Last acquisition by Outset Medical was on XXXXXXXX, XXXXX. Outset Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Outset Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOutset Medical Investment Activity
Outset Medical invested in XXX companies to date.
Outset Medical made its latest investment on XXXXXXXX, XXXXX. Outset Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Outset Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Outset Medical
| When was Outset Medical founded? | Outset Medical was founded in 2003. |
| Where is Outset Medical headquartered? | Outset Medical is headquartered in United States. |
| How many employees does Outset Medical have? | As of today, Outset Medical has over 310 employees. |
| Who is the CEO of Outset Medical? | Outset Medical's CEO is Leslie L. Trigg. |
| Is Outset Medical publicly listed? | Yes, Outset Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Outset Medical? | Outset Medical trades under OM ticker. |
| When did Outset Medical go public? | Outset Medical went public in 2020. |
| Who are competitors of Outset Medical? | Outset Medical main competitors are electroCore, Pangaea Oncology, Optomed, Accuray. |
| What is the current market cap of Outset Medical? | Outset Medical's current market cap is $64M. |
| What is the current revenue of Outset Medical? | Outset Medical's last 12 months revenue is $121M. |
| What is the current revenue growth of Outset Medical? | Outset Medical revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Outset Medical? | Current revenue multiple of Outset Medical is (0.0x). |
| Is Outset Medical profitable? | No, Outset Medical is not profitable. |
| What is the current EBITDA of Outset Medical? | Outset Medical has negative EBITDA and is not profitable. |
| What is Outset Medical's EBITDA margin? | Outset Medical's last 12 months EBITDA margin is (37%). |
| What is the current EV/EBITDA multiple of Outset Medical? | Current EBITDA multiple of Outset Medical is 0.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.